Relationship between PD-L1 expression and [18F]FAPI versus [18F]FDG uptake on PET/CT in lung cancer

IF 8.6 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING European Journal of Nuclear Medicine and Molecular Imaging Pub Date : 2025-03-21 DOI:10.1007/s00259-025-07201-6
Jingjie Qin, Chao Han, Haoqian Li, Zhendan Wang, Xudong Hu, Lanping Liu, Shouhui Zhu, Jingjing Zhao, Yuhong Sun, Yuchun Wei
{"title":"Relationship between PD-L1 expression and [18F]FAPI versus [18F]FDG uptake on PET/CT in lung cancer","authors":"Jingjie Qin, Chao Han, Haoqian Li, Zhendan Wang, Xudong Hu, Lanping Liu, Shouhui Zhu, Jingjing Zhao, Yuhong Sun, Yuchun Wei","doi":"10.1007/s00259-025-07201-6","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>To investigate the correlation between [<sup>18</sup>F] labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography (PET)/computed tomography (CT) uptake and programmed death ligand 1 (PD-L1) expression in lung cancer and evaluate the predictive value of [<sup>18</sup>F]FAPI PET/CT for PD-L1 expression compared with [<sup>18</sup>F]fluorodeoxyglucose ([<sup>18</sup>F]FDG) PET/CT.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>This single-center retrospective study consecutively enrolled patients with pathologically confirmed lung cancer who underwent [<sup>18</sup>F]FAPI and [<sup>18</sup>F]FDG PET/CT scans within 2 weeks, with a minimum interval of 20 h. PD-L1 expression was assessed using immunohistochemistry and stratified into three groups. PET/CT uptake parameters included the maximum standard uptake value (SUV<sub>max</sub>) in the biopsy tumor or mediastinal metastasis lymph nodes area and the mean SUV<sub>s</sub> (SUV<sub>mean</sub>) of normal tissue (lung and blood). The ratios of SUV<sub>max</sub> to the SUV<sub>mean</sub> for each normal tissue were denoted as the tumor-to-background ratios (TBR<sub>lung</sub> and TBR<sub>blood</sub>). All statistical analyses were conducted using IBM SPSS Statistics. Normality was assessed, and for non-normally distributed data, the Kruskal-Wallis and Mann-Whitney U tests were applied. Associations between variables were evaluated using Spearman’s rank correlation. All tests were two-sided, with a <i>P</i>-value &lt; 0.05 considered statistically significant.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Among the 75 cases included on the final analysis, the TBR<sub>blood</sub> and TBR<sub>lung</sub> derived from [<sup>18</sup>F]FAPI PET/CT were significantly positively correlated with PD-L1 expression (<i>r</i> = 0.32, <i>P</i> &lt; 0.01; <i>r</i> = 0.26, <i>P</i> &lt; 0.05). Additionally, cases with high PD-L1 expression showed significantly higher [<sup>18</sup>F]FAPI uptake values (mean TBR<sub>lung</sub>=36.16; mean TBR<sub>blood</sub>=10.75) compared with those with low PD-L1 expression (mean TBR<sub>lung</sub>=25.10; mean TBR<sub>blood</sub>=8.04). No statistically significant correlation was observed between [<sup>18</sup>F]FDG uptake values and PD-L1 expression level. Receiver operating characteristic analysis identified TBR<sub>blood</sub> on [<sup>18</sup>F]FAPI PET/CT with a cutoff value of 7.76 (area under the curve = 0.68, <i>P</i> &lt; 0.01, sensitivity = 75%, and specificity = 53.49%) as a significant predictor of the level of PD-L1 expression.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>[<sup>18</sup>F]FAPI uptake was positively correlated with PD-L1 expression in lung cancer. The combination of [<sup>18</sup>F]FAPI PET/CT and PD-L1 expression may offer a more comprehensive approach to assessing the response of lung cancer to immunotherapy.</p><h3 data-test=\"abstract-sub-heading\">Trial registration</h3><p>This study was approved by the Clinical Research Ethics Committee of our institution (institutional review board approval no. SDZLEC2021–112–02).</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":"37 1","pages":""},"PeriodicalIF":8.6000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-025-07201-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

To investigate the correlation between [18F] labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography (PET)/computed tomography (CT) uptake and programmed death ligand 1 (PD-L1) expression in lung cancer and evaluate the predictive value of [18F]FAPI PET/CT for PD-L1 expression compared with [18F]fluorodeoxyglucose ([18F]FDG) PET/CT.

Methods

This single-center retrospective study consecutively enrolled patients with pathologically confirmed lung cancer who underwent [18F]FAPI and [18F]FDG PET/CT scans within 2 weeks, with a minimum interval of 20 h. PD-L1 expression was assessed using immunohistochemistry and stratified into three groups. PET/CT uptake parameters included the maximum standard uptake value (SUVmax) in the biopsy tumor or mediastinal metastasis lymph nodes area and the mean SUVs (SUVmean) of normal tissue (lung and blood). The ratios of SUVmax to the SUVmean for each normal tissue were denoted as the tumor-to-background ratios (TBRlung and TBRblood). All statistical analyses were conducted using IBM SPSS Statistics. Normality was assessed, and for non-normally distributed data, the Kruskal-Wallis and Mann-Whitney U tests were applied. Associations between variables were evaluated using Spearman’s rank correlation. All tests were two-sided, with a P-value < 0.05 considered statistically significant.

Results

Among the 75 cases included on the final analysis, the TBRblood and TBRlung derived from [18F]FAPI PET/CT were significantly positively correlated with PD-L1 expression (r = 0.32, P < 0.01; r = 0.26, P < 0.05). Additionally, cases with high PD-L1 expression showed significantly higher [18F]FAPI uptake values (mean TBRlung=36.16; mean TBRblood=10.75) compared with those with low PD-L1 expression (mean TBRlung=25.10; mean TBRblood=8.04). No statistically significant correlation was observed between [18F]FDG uptake values and PD-L1 expression level. Receiver operating characteristic analysis identified TBRblood on [18F]FAPI PET/CT with a cutoff value of 7.76 (area under the curve = 0.68, P < 0.01, sensitivity = 75%, and specificity = 53.49%) as a significant predictor of the level of PD-L1 expression.

Conclusion

[18F]FAPI uptake was positively correlated with PD-L1 expression in lung cancer. The combination of [18F]FAPI PET/CT and PD-L1 expression may offer a more comprehensive approach to assessing the response of lung cancer to immunotherapy.

Trial registration

This study was approved by the Clinical Research Ethics Committee of our institution (institutional review board approval no. SDZLEC2021–112–02).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
15.60
自引率
9.90%
发文量
392
审稿时长
3 months
期刊介绍: The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.
期刊最新文献
Relationship between PD-L1 expression and [18F]FAPI versus [18F]FDG uptake on PET/CT in lung cancer New compartment model for hepatic blood flow quantification in humans from 15O-water PET images Diagnostic accuracy in NSCLC lymph node staging with Total-Body and conventional PET/CT Prognostic value of [18F]FDG- and PSMA-PET in patients evaluated for [177Lu]Lu-PSMA therapy of mCRPC Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1